Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Elder Granger

Showing results (1-10 of 23) with videos related to

Pageof 3
Sort By:
Frontiers in Molecular Biosciences|June 7, 2024
Performance evaluation of a SARS-CoV-2 and influenza A/B combo rapid antigen testKevin P Rosenblatt, Hugo Romeu, Camille Romeu, et al.
International Journal of Adolescent Medicine and Health|June 17, 2009
The association between oseltamivir use and adverse neuropsychiatric outcomes among TRICARE beneficiaries, ages 1 through 21 years diagnosed with influenzaS Ward Casscells, Elder Granger, Amii M Kress, et al.
Military Medicine|August 25, 2010
Historical evolution of medical quality assurance in the Department of DefenseElder Granger, John Boyer, Richard Weiss, et al.
Military Medicine|May 23, 2018
Return-to-Duty Rates Following Minimally Invasive Spine Surgery Performed on Active Duty Military Patients in an Ambulatory Surgery CenterElder Granger, Stefan Prada, Zoltan Bereczki, et al.
Military Medicine|February 14, 2026
Return to Duty Rates in Active-Duty Military: Comparing Minimally Invasive and Open Cervical Spine SurgeryElder Granger, Kaitlyn Armstrong, Corbit Franks, et al.
Journal of Racial and Ethnic Health Disparities|September 9, 2020
Ethnic Prevalence of Angiotensin-Converting Enzyme Deletion (D) Polymorphism and COVID-19 Risk: Rationale for Use of Angiotensin-Converting Enzyme Inhibitors/Angiotensin Receptor BlockersRangaprasad Sarangarajan, Robert Winn, Michael A Kiebish, et al.
Circulation. Cardiovascular Quality and Outcomes|December 25, 2009
Use of oseltamivir after influenza infection is associated with reduced incidence of recurrent adverse cardiovascular outcomes among military health system beneficiaries with prior cardiovascular diseasesS Ward Casscells, Elder Granger, Amii M Kress, et al.
Journal of the National Medical Association|July 29, 2009
Racial and ethnic health disparities in TRICAREAnn D Bagchi, Eric Schone, Patricia Higgins, et al.
Pharmacoepidemiology and Drug Safety|August 6, 2009
Temporal trends in anti-diabetes drug use in TRICARE following safety warnings in 2007 about rosiglitazoneKate A Stewart, Brenda M Natzke, Thomas Williams, et al.
American Journal of Therapeutics|May 23, 2008
A comparison of select cardiovascular outcomes by antidiabetic prescription drug classes used to treat type 2 diabetes among Military Health System beneficiaries, fiscal year 2003-2006S Ward Casscells, Elder Granger, Joe Swedorske, et al.
Pageof 3

Showing results (1-10 of 23) with videos related to

Sort By:
Pageof 3
Frontiers in Molecular Biosciences|June 7, 2024
Performance evaluation of a SARS-CoV-2 and influenza A/B combo rapid antigen testKevin P Rosenblatt, Hugo Romeu, Camille Romeu, et al.
International Journal of Adolescent Medicine and Health|June 17, 2009
The association between oseltamivir use and adverse neuropsychiatric outcomes among TRICARE beneficiaries, ages 1 through 21 years diagnosed with influenzaS Ward Casscells, Elder Granger, Amii M Kress, et al.
Military Medicine|August 25, 2010
Historical evolution of medical quality assurance in the Department of DefenseElder Granger, John Boyer, Richard Weiss, et al.
Military Medicine|May 23, 2018
Return-to-Duty Rates Following Minimally Invasive Spine Surgery Performed on Active Duty Military Patients in an Ambulatory Surgery CenterElder Granger, Stefan Prada, Zoltan Bereczki, et al.
Military Medicine|February 14, 2026
Return to Duty Rates in Active-Duty Military: Comparing Minimally Invasive and Open Cervical Spine SurgeryElder Granger, Kaitlyn Armstrong, Corbit Franks, et al.
Journal of Racial and Ethnic Health Disparities|September 9, 2020
Ethnic Prevalence of Angiotensin-Converting Enzyme Deletion (D) Polymorphism and COVID-19 Risk: Rationale for Use of Angiotensin-Converting Enzyme Inhibitors/Angiotensin Receptor BlockersRangaprasad Sarangarajan, Robert Winn, Michael A Kiebish, et al.
Circulation. Cardiovascular Quality and Outcomes|December 25, 2009
Use of oseltamivir after influenza infection is associated with reduced incidence of recurrent adverse cardiovascular outcomes among military health system beneficiaries with prior cardiovascular diseasesS Ward Casscells, Elder Granger, Amii M Kress, et al.
Journal of the National Medical Association|July 29, 2009
Racial and ethnic health disparities in TRICAREAnn D Bagchi, Eric Schone, Patricia Higgins, et al.
Pharmacoepidemiology and Drug Safety|August 6, 2009
Temporal trends in anti-diabetes drug use in TRICARE following safety warnings in 2007 about rosiglitazoneKate A Stewart, Brenda M Natzke, Thomas Williams, et al.
American Journal of Therapeutics|May 23, 2008
A comparison of select cardiovascular outcomes by antidiabetic prescription drug classes used to treat type 2 diabetes among Military Health System beneficiaries, fiscal year 2003-2006S Ward Casscells, Elder Granger, Joe Swedorske, et al.
Pageof 3